Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Daniel O'Day

Daniel O'Day

Chief Executive, Gilead Sciences

Appears in 1 story

Notable Quotes

We are pricing for access in the places where the need is greatest.

Stories

A twice-yearly HIV shot arrives as funding to deliver it shrinks

New Capabilities

Steering lenacapavir pricing and supply deals

A single shot, twice a year, prevented HIV in nearly everyone who received it in late-stage trials. The question at AIDS 2026, which opened in Rio de Janeiro on July 26, is whether that shot reaches the people who need it.

Updated 2 hours ago